Calumet Specialty Products Partners (CLMT) Misses Q3 EPS by 32c

Calumet Specialty Products Partners (NASDAQ: CLMT) reported Q3 EPS of ($0.42), $0.32 worse than the analyst estimate of ($0.10). Revenue for the quarter came in at $966 million versus the consensus estimate of $874.36 million.

For earnings history and earnings-related data on Calumet Specialty Products Partners (CLMT) click here.

You May Also Be Interested In

• SanDisk upgraded at JPMorgan after investor day; shares climb
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
• Stardust Power (SDST) Tops Q2 EPS by 1c